We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Els anticossos són un dels elements fonamentals en la resposta immunitària contra les infeccions. No obstant això, hi ha anticossos que, en lloc d'activar una resposta immunitària, són utilitzats per els microorganismes per augmentar la seva capacitat infectant. Són els anticossos no neutralitzants en el cas de les infeccions víriques, o bloquejants en les infeccions bacterianes. L'eliminació selectiva d'aquests anticossos genera immunitat protectora contra les infeccions, i constitueix una nova forma de tractament de les mateixes.
CV: Rafael Mañez es va llicenciar en Medicina el 1981, i doctorar el 1990, a la Universitat Autònoma de Barcelona. Va completar la seva formació en Medicina Intensiva el 1987 a l'Hospital Universitari Valle Hebron (Barcelona). Del 1990 al 1994, va ser professor associat a l'Institut de Trasplantament de la Universitat de Pittsburgh (Pittsburgh, EUA). Del 1995 al 1996 va ser subdirector mèdic a l'Hospital Universitari de Bellvitge i, del 1996 al 2003, director mèdic de trasplantaments, i de la recerca en xenotransplantament, a l'Hospital Universitari de la Corunya. Des del 2003 dirigeix el Departament de Medicina Intensiva de l’Hospital Universitari de Bellvitge i el grup de recerca “Immunitat innata i patologia del pacient malalt crític” de l’IDIBELL. Ha publicat 163 articles (índex H 41), ha omplert dues patents i ha estat un dels fundadors de la spin-off IDABELL RemAb Therapeutics.
Ja està disponible l’enllaç per apuntar-s’hi.
Inscriu-t'hi
La inscripció és gratuïta
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.